Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1321, 2002-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Homocysteine-lowering therapy cost effective in CHD?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 346, 2002-01 ,pp. :
Access to resources
Recommend
Homocysteine-lowering therapy lowers risk of CHD?
Inpharma, Vol. 1, Iss. 1225, 2000-01 ,pp. :
Antibacterials for the treatment of CHD?
Inpharma, Vol. 1, Iss. 1386, 2003-01 ,pp. :
PTCA preferable in nonacute CHD?
Inpharma, Vol. 1, Iss. 1246, 2000-01 ,pp. :
Rethink use of statins for primary prevention in CHD?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 269, 2000-01 ,pp. :